Eli Lilly Inks $1B Deal For Non-Opioid Pain-Drug Maker

By Craig Clough · May 27, 2025, 3:22 PM EDT

Eli Lilly announced Tuesday that it has inked a potentially $1 billion deal to buy SiteOne Theraputics, giving the pharmaceutical giant access to a non-opiod pain medicine ready for phase 2...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login